Cargando…
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model
Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease characterized by the aberrant accumulation of extracellular matrix in the lungs. nintedanib is one of the two FDA-approved drugs for IPF treatment; however, the exact pathophysiological mechanisms of fibrosis progression and response to t...
Autores principales: | Principi, Lucrezia, Ferrini, Erica, Ciccimarra, Roberta, Pagani, Lisa, Chinello, Clizia, Previtali, Paolo, Smith, Andrew, Villetti, Gino, Zoboli, Matteo, Ravanetti, Francesca, Stellari, Franco Fabio, Magni, Fulvio, Piga, Isabella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10002924/ https://www.ncbi.nlm.nih.gov/pubmed/36901840 http://dx.doi.org/10.3390/ijms24054410 |
Ejemplares similares
-
Indocyanine-enhanced mouse model of bleomycin-induced lung fibrosis with hallmarks of progressive emphysema
por: Grandi, Andrea, et al.
Publicado: (2023) -
In-vivo lung fibrosis staging in a bleomycin-mouse model: a new micro-CT guided densitometric approach
por: Mecozzi, Laura, et al.
Publicado: (2020) -
Modeling pulmonary fibrosis through bleomycin delivered by osmotic minipump: a new histomorphometric method of evaluation
por: Ravanetti, Francesca, et al.
Publicado: (2020) -
The normal and fibrotic mouse lung classified by spatial proteomic analysis
por: Ciccimarra, Roberta, et al.
Publicado: (2022) -
SSC-ILD mouse model induced by osmotic minipump delivered bleomycin: effect of Nintedanib
por: Ravanetti, Francesca, et al.
Publicado: (2021)